Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

CONTEXT: Adrenal tumors have a prevalence of around 2% in the general population. Adrenocortical carcinoma (ACC) is rare but accounts for 2–11% of incidentally discovered adrenal masses. Differentiating ACC from adrenocortical adenoma (ACA) represents a diagnostic challenge in patients with adrenal...

Descripción completa

Detalles Bibliográficos
Autores principales: Arlt, Wiebke, Biehl, Michael, Taylor, Angela E., Hahner, Stefanie, Libé, Rossella, Hughes, Beverly A., Schneider, Petra, Smith, David J., Stiekema, Han, Krone, Nils, Porfiri, Emilio, Opocher, Giuseppe, Bertherat, Jerôme, Mantero, Franco, Allolio, Bruno, Terzolo, Massimo, Nightingale, Peter, Shackleton, Cedric H. L., Bertagna, Xavier, Fassnacht, Martin, Stewart, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2011
Materias:
Endocrine Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232629/
https://www.ncbi.nlm.nih.gov/pubmed/21917861
http://dx.doi.org/10.1210/jc.2011-1565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232629/
https://www.ncbi.nlm.nih.gov/pubmed/21917861
http://dx.doi.org/10.1210/jc.2011-1565

Ejemplares similares